Posts

Showing posts from October 12, 2014
Image
Tamale (pronounced tamalɛ)[need tone] is a town officially called Tamale Metropolitan District. Tamale has a projected population of 537,986 according to the 2010 census, making it the fastest growing city in West Africa. The town is located 600 km north of Accra. Most Tamale residents are moderate followers of Islam, as reflected by the multitude of mosques in Tamale, most notably the Central Mos que. The Sunnites and the Ahmadiyyans also have their own central mosques, north of the town centre along Bolgatanga Road. Tamale is located in Northern region and more precisely in the Dagbon Kingdom. The local (neighbourhood) chiefs and the district chief of Tamale are subservient to the Dagomba Paramount Chief (King) in Yendi. Due to Tamale central location, Tamale serves as a hub for all administrative and commercial activities in Northern region, doubling as the political, economic and financial capital of Northern region. The center of Tamale hosts regional branches o
Image
Efforts to develop a vaccine have been funded in the main by the US Department of Defense and the National Institutes of Health. They have poured millions of dollars into scientific research. As a result of this funding, several vaccine candidates have been developed and have shown themselves effective in animal trials.  Two companies, Sarepta and Tekmira have begun human safety trials of their vaccines. But in recent days, both companies have been told by the Defense Department to temporarily stop work on their vaccines due to funding constraints. It is expected that a decision to either resume testing or completely terminate the contracts will be made by early September. Scientists say their understanding of the nature of the virus has markedly improved over the past decade. But the chances of turning that knowledge into a vaccine are very dependent on money.   All about the money Gene Olinger, a virologist at the US Army Research Institute
Image
Dr. Kent Brantly was given the medication, ZMapp, shortly after telling his doctors he thought he would die, according to a source familiar with his case. Within an hour, doctors say his symptoms -- labored breathing and a widespread rash -- dramatically improved. Nancy Writebol, another missionary working with Samaritan's Purse, received two doses of the medication and has also shown significant improvement, sources say. As there is no proven treatment and no vaccine for Ebola, this experimental drug is raising lots of questions. 1. Who makes the drug? The drug was developed by the biotech firm Mapp Biopharmaceutical Inc ., which is based in San Diego. The company was founded in 2003 "to develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense," according to its website . Mapp Biopharmaceutical has been working with the National Institutes of Health and the De
Image
WHAT IF EBOLA FINES IT WAY TO GHANA? WHAT WILL BE THE OUR PLAN ''B'' ? The most disturbing issue at hand is the health of the individual, and when the health of the citizens is been politicize, when the citizens lose confidence in their politicians and decision makes, life becomes more hell for the youth and newly born children. Ebola we all know might fine it way to Ghana, although the health ministry says The Minister for Health, Dr. Kwaku Agyeman Mensah, while touring the Ebola-preparedness facilities at the Kotoka International Airport, questioned the University’s findings, insisting that they were satisfied with the measures that had been put in place to prevent an outbreak in the country. “I don’t know how they came by that date [October 31] or how they did their analysis. But I want to assure you that in Ghana we have Ebola preparedness and a response plan underpinned by a three-pronged strategy; public education, screening and effective case mana